English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
12 results
Furo[2, 3d]pyrimidine derivatives and anti-ulcer containing the same
Only registered users can translate articles
Log In/Sign up
The present invention relates to furo[2, 3d]pyrimidine derivatives having the general formula (I) ##STR2## wherein R.sub.1 represents a lower alkyl, a lower alkenyl or an aralkyl group, and R.sub.2 represents a lower alkyl, unsubstituted phenyl, carboxyl, methylsulphonyl, methoxycarbonyl or a
1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Platelet-activating factor (PAF) has recently been identified as an acetyl glyceryl ether phosphorylcholine (AGEPC), i.e., 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (Hanahan D. J. et al., J. Biol. Chem. 255:5514, 1980). Even before its chemical
1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Platelet-activating factor (PAF) has recently been identified as an acetyl glyceryl ether phosphorylcholine (AGEPC), i.e., 1-0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorycholine (Hanahan D. J., et al., J. Biol. Chem. 255:5514, 1980). Even before its chemical
Antibody against NPW
Only registered users can translate articles
Log In/Sign up
TECHNICAL FIELD
The present invention relates to a novel antibody having a binding specificity to a polypeptide comprising an amino acid sequence represented by SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10 or SEQ ID NO: 11, or a salt thereof. More
Hyaluronic acid-urea pharmaceutical compositions and uses
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Hyaluronic acid-urea pharmaceutical compositions and uses
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Hyaluronic acid-urea pharmaceutical compositions and uses
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Hyaluronic acid-urea pharmaceutical compositions and uses
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
Only registered users can translate articles
Log In/Sign up
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the aforementioned compositions. The
Method of treating an anorectal disease using hyaluronic acid-urea pharmaceutical compositions
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Method of treating lesions resulting from genital herpes with hyaluronic acid-urea pharmaceutical compositions
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The present invention concerns pharmaceutical compositions which include urea and hyaluronic acid or derivatives of hyaluronic acid. The present invention further concerns methods of treating disease of the cutis, anorectal epithelium and rectal mucosa employing the
Self-powered compression devices and methods for promoting circulation and therapeutic compression
Only registered users can translate articles
Log In/Sign up
1. FIELD OF THE INVENTION
The present invention relates to self-powered compression devices and methods for promoting circulation and therapeutic compression in mammals in general or an individual in need thereof. More particularly, the invention is in the class of medical devices, comprising a
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
